We find that BRCA2-mutant tumours upregulate interferon pathway genes (Supplementary Fig. 10c), in line with our findings and previous reports39, suggesting this response is conserved between mouse models and human tumour data. This evidence concerns the gene BRCA2 and neoplasm.